Report Company Directory
- Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc. by GlobeNewsWire
- Ritter Pharmaceuticals, Inc. Announces Stockholder Approval of Proposals Required for Merger Transaction with Qualigen, Inc. by GlobeNewsWire
- Ritter Pharmaceuticals, Inc. Announces Adjournment of its Special Meeting by GlobeNewsWire
- Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Stockholders’ Equity Requirement for Continued Listing by GlobeNewsWire
- Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each of the Merger Proposals by GlobeNewsWire
- Ritter Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2020 by GlobeNewsWire
- Ritter Pharmaceuticals, Inc. Urges Stockholders to Vote Now on Proposed Merger with Biotech Company, Qualigen Inc. by GlobeNewsWire
- Ritter Pharmaceuticals, Inc. Announces Form S-4 Registration Statement Declared Effective by SEC by GlobeNewsWire
- Ritter Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2019 by GlobeNewsWire
- Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement by GlobeNewsWire